This infographic reveals the breast cancer screening practices of fellow ObGyn.net readers. How do your recommendations compare with those of your colleagues?
[[{"type":"media","view_mode":"media_crop","fid":"25281","attributes":{"alt":"2014 Breast Cancer Screening Survey Results","class":"media-image","id":"media_crop_3167291278950","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"2296","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","title":" ","typeof":"foaf:Image"}}]]
The results of our 2014 Breast Cancer Screening Survey are in! This infographic highlights the breast cancer screening practices of more than 550 Ob/Gyns and other women’s health clinicians. Unsurprisingly, mammography is the most preferred method of breast cancer screening.
Of note is that despite the 2009 guidelines from the U.S. Preventive Services Task Force (USPSTF) recommending biennial screening for average-risk women aged 50 to 75 years old, more than half (59%) of all ob/gyns surveyed recommend women begin screening at age 40, and nearly half of respondents (48%) suggest annual screening.
The USPSTF is currently updating its recommendation for breast cancer screening. Part of this update involves evaluating the benefit of screening average risk women aged 40 and older and whether screening mammography should be combined with another screening modality, such as MRI or ultrasound. The full draft Research Plan is available here: http://www.uspreventiveservicestaskforce.org/uspstf14/breastcancer/breastcandraftresplan.htm.
Shift towards neoadjuvant chemotherapy found in ovarian cancer treatment
October 21st 2024A recent study shows a significant decrease in primary cytoreductive surgery utilization for advanced ovarian cancer, as neoadjuvant chemotherapy followed by interval cytoreductive surgery gains acceptance for its noninferior survival outcomes and reduced postoperative morbidity.
Read More
S1E4: Dr. Kristina Adams-Waldorf: Pandemics, pathogens and perseverance
July 16th 2020This episode of Pap Talk by Contemporary OB/GYN features an interview with Dr. Kristina Adams-Waldorf, Professor in the Department of Obstetrics and Gynecology and Adjunct Professor in Global Health at the University of Washington (UW) School of Medicine in Seattle.
Listen
Family history criteria used to predict breast cancer genetic risk variants
September 26th 2024In a recent study, patients with a positive response to the Seven-Question Family History Questionnaire were more likely to present with a pathogenic or likely pathogenic variant in the BRCA1 and BRCA2 genes.
Read More